Endometrial adenocarcinoma and PTEN expression and the relationship between CyclinE.docVIP

 PAGE \* MERGEFORMAT 15 Endometrial adenocarcinoma and PTEN expression and the relationship between CyclinE [Abstract] Objective To investigate endometrial adenocarcinoma and precancerous lesions in the PTEN, CyclinE protein expression in endometrial adenocarcinoma and its clinical and pathological features. Immunohistochemical SP method detected in normal endometrium , endometrial hyperplasia, atypical endometrial hyperplasia and endometrial adenocarcinoma and CyclinE PTEN expression. Results and CyclinE PTEN protein in endometrial atypical hyperplasia group, positive expression rate was 50.00%, 60.00 %, in endometrial adenocarcinoma were positive expression group was 45.45% and 65.50%. both groups were lower than in the positive expression of PTEN in normal endometrium and endometrial hyperplasia group (P lt;0.01, while the positive expression of CyclinE were higher than in normal endometrium and endometrial hyperplasia group (P lt;0.01.PTEN and CyclinE protein expression in endometrial atypical hyperplasia and endometrial adenocarcinoma group, the expression was negatively correlated (r =- 0.61, P lt;0.05, r =- 0.49, P lt;0.01. carcinoma in the absence of PTEN expression and histological grade, myometrial invasion, or associated with metastasis and clinical stage (P lt;0.01 or P lt;0.05. The positive rate of CyclinE and histological grade (P lt;0.01. cancer group, tumor recurrence and loss of expression of PTEN and overexpression of both CyclinE on (P lt;0.01. Conclusion CyclinE PTEN expression loss and overexpression of the uterus involved endometrioid adenocarcinoma, the development process and is closely related with tumor recurrence, combined detection of both endometrial adenocarcinoma as early diagnosis, to determine the biological behavior of tumor targets. [Keywords:] Carcinoma, Endometrioid, biological markers, PTEN, CyclinE Abstract: Objective To investigate the PTEN and CyclinE protein expression in endometrioid adenocarcinoma and precanc